XML 45 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Collaboration agreements - Merck Immunosythen Agreement (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2023
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
target
performanceObligation
Dec. 31, 2021
USD ($)
Collaboration agreements              
Collaboration revenue   $ 10,654 $ 4,284 $ 18,456 $ 6,320    
Deferred revenue   134,697 $ 37,914 134,697 $ 37,914 $ 147,653 $ 3,944
2022 Merck Research Collaboration & License Agreement              
Collaboration agreements              
Number of targets designated | target           2  
Upfront payment received $ 30,000            
Performance obligations identified | performanceObligation           4  
Collaboration revenue   2,500   5,600      
Deferred revenue   $ 25,400   $ 25,400   $ 30,000